New guidelines address primary cutaneous T-cell lymphoproliferative disorders
HOLLYWOOD, FLA. – The treatment of patients with lymphomatoid papulosis depends on the presentation, according to new National Comprehensive Cancer Network guidelines for managing primary cutaneous CD30+ T-cell lymphoproliferative disorders.
The Oncology Report - Wed, 16 Apr 2014 11:02

Hyundai Hope On Wheels Announces 2014-2015 National Youth Ambassadors
Several months later she developed Post-Transplant Lymphoproliferative Disorder/Non-Hodgkin's Lymphoma. Over the next two years, she endured multiple rounds of chemo, a stem cell transplant, care at three different children's hospitals, and countless ...
PR Newswire (press release) - Wed, 16 Apr 2014 05:00

Children's Discovery Institute awards $3.1 million in pediatric research grants
Their aim is to expand understanding of post-transplant lymphoproliferative disorder (PTLD). This malignant transformation of white blood cells can occur in recipients of solid-organ or tissue transplants and may lead to death. While many cases of PTLD ...
Washington University in St. Louis News - Mon, 14 Apr 2014 13:03

Horses provide 'magical' therapy for valley's heroes and their families
They are her escape from the hours spent inside sterile hospitals getting poked with syringes full of steroids and vitamins to control her rare blood disease. Sophie suffers autoimmune lymphoproliferative syndrome (ALPS), a sickness that destroys her ...
Las Vegas Sun - Fri, 21 Mar 2014 02:00

Most Popular Stories
Some people who have taken XELJANZ with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control (Epstein Barr virus-associated post-transplant lymphoproliferative disorder).
Fort Mills Times - Sat, 22 Mar 2014 08:45


Last update: April 2009